CASI Pharmaceuticals, Inc. 4
4 · CASI Pharmaceuticals, Inc. · Filed Mar 4, 2016
Insider Transaction Report
Form 4
Salisbury Franklin Cary jr
Director
Transactions
- Award
Stock Options (Right to Buy)
[F1]2016-03-02+35,000→ 35,000 totalExercise: $0.88Exp: 2026-03-02→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]Stock option award will vest ratably quarterly to the end of one year.
Signature
/s/ Cynthia W. Hu, attorney-in-fact for Franklin Salisbury|2016-03-04